Deerfield Special Situations Fund, L.P., 10% Owner at ANTARES PHARMA, INC. (ATRS), sold 756,852 shares at $2.34 ($1.7M) on 2015-06-24, disclosed to the SEC on 2015-06-26.
Open-market sale of $1.7M ATRS by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.29 | 41,245 | $94K | 5.5% |
| 2 | $2.29 | 52,494 | $120K | 7.0% |
| 3 | $2.29 | 17,427 | $40K | 2.3% |
| 4 | $2.30 | 29,214 | $67K | 3.9% |
| 5 | $2.30 | 12,344 | $28K | 1.7% |
| 6 | $2.30 | 37,181 |
| $86K |
| 5.0% |
| 7 | $2.34 | 11,477 | $27K | 1.6% |
| 8 | $2.34 | 27,164 | $64K | 3.7% |
| 9 | $2.34 | 34,572 | $81K | 4.7% |
| 10 | $2.25 | 16,021 | $36K | 2.1% |
| 11 | $2.25 | 11,444 | $26K | 1.5% |
| 12 | $2.25 | 27,085 | $61K | 3.6% |
| 13 | $2.25 | 34,471 | $78K | 4.5% |
| 14 | $2.25 | 37,919 | $85K | 5.0% |
| 15 | $2.25 | 48,260 | $109K | 6.3% |
| 16 | $2.24 | 33,627 | $75K | 4.4% |
| 17 | $2.24 | 79,586 | $178K | 10.4% |
| 18 | $2.24 | 101,291 | $227K | 13.2% |
| 19 | $2.25 | 16,308 | $37K | 2.1% |
| 20 | $2.25 | 38,598 | $87K | 5.1% |
| 21 | $2.25 | 49,124 | $111K | 6.4% |
| Total | $2.27 avg | 756,852 | $1.7M | 100% |
| Filing → |
| VNDA | BUY | 2015-12-18 | $3.7M | — | Filing → |
| VNDA | BUY | 2015-12-11 | $6.4M | — | Filing → |
| ALIM | BUY | 2015-12-08 | $494K | — | Filing → |